“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...

Anna Chorniy does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Add Yahoo as a preferred source to see more of our stories on Google. The United States is one of just two countries where drugmakers can advertise directly to patients. BrianAJackson/iStock via Getty ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Chorniy, Icahn School of Medicine at Mount Sinai; Institute for Humane Studies ...